What is sermorelin
Sermorelin is a synthetic compound modeled on a natural releasing hormone, the signal your hypothalamus sends to the pituitary gland.
If you have searched what is sermorelin and found pages calling it a hormone, correct that first. Sermorelin is not a hormone itself. It is a medication that asks your pituitary to make more of its own, and that distinction decides how it behaves, how it is dosed and what it can and cannot do.
Its history is unusual for a clinic treatment. The FDA approved sermorelin under the brand name Geref in December 1990 as a diagnostic agent, and again in September 1997 as a treatment for children with a hormone deficiency. EMD Serono, the approval holder, later took both products off the market. In March 2013 the FDA published a formal determination that the withdrawal was not for reasons of safety or effectiveness, the finding that clears the way for generic applications.
None have been filed. No FDA-approved sermorelin product is sold in the United States today.
What clinics prescribe instead is a compounded version, prepared by a pharmacy for one patient under a prescription. On this the FDA is direct: compounded drugs are not FDA approved, and the agency does not verify their safety, effectiveness or quality before they are marketed. Compounded medicine is lawful and often necessary, so that is no reason to avoid it. It is a reason to care who prescribes it, which pharmacy fills it and what is in the vial.
How sermorelin works in the body
Your pituitary releases its hormones in pulses, and the largest ones arrive during deep sleep. Two signals set that rhythm. A natural releasing hormone tells the gland to release, and somatostatin tells it to stop. Sermorelin copies the first signal.
After a subcutaneous injection, sermorelin binds the same pituitary receptors the natural releasing hormone uses and strengthens the next pulse. Your provider then follows the effect with a blood marker. That marker is the number your provider tracks, since the hormone itself rises and falls too fast to read from one morning draw.
Because the pituitary stays in charge, the brakes stay on. Somatostatin still limits each pulse. Your body’s normal feedback still slows release. That is the case clinicians make for sermorelin over injected hormones, which bypass the gland and have to be dosed by estimate against lab readings. A 2006 review in Clinical Interventions in Aging that laid out this argument also noted a paradox: sermorelin failed commercially as a growth treatment for children because it could not compete with synthetic hormone products, and that same restraint is why some clinicians prefer it for adults, whose goal is a modest return toward earlier output rather than growth.
“Sermorelin does not add a hormone to your body. It asks your pituitary to make more of its own.”
Two practical limits follow. Sermorelin can only raise output as far as your own pituitary can go, so it suits nobody whose gland is damaged or absent. And since it works through a sleep-time pulse, it is given in the evening, on a schedule the provider sets.
Sermorelin benefits & side effects
Most of what you will read about sermorelin before and after results comes from clinic pages and patient forums, not controlled trials. The research record in adults is small, old and short.
Reported benefits
The best known adult studies date from 1997. In one, eleven healthy men aged 64 to 76 with low hormone markers self-injected a similar compound nightly for six weeks. Nighttime hormone release rose and two of six strength measures improved, while weight and body composition did not change, and the authors concluded that a single nightly dose is less effective than divided doses. In a second trial, 19 healthy older adults used a similar compound nightly for 16 weeks after four weeks of placebo. Hormone output rose within four weeks and several immune cell counts shifted, but the study was small and never designed to test how people felt or performed day to day.
So the measured sermorelin effects are a rise in your own hormone output, plus an early signal on strength in older men. Better sleep is what patients describe most often, though the trials didn’t measure it and individual results vary. Nobody has them in trials of sermorelin for aging adults.
That gap matters when you read a clinic page. A claim that sermorelin addresses aging or restores youthful sleep is a claim about outcomes nobody has measured in a controlled way. What a careful provider can promise is narrower: a tested baseline, a tested response and an honest conversation about what changed.
Possible side effects
Sermorelin side effects in the trials above were unremarkable. Neither 1997 study recorded significant adverse effects over six to 16 weeks of nightly use. Like any medicine injected under the skin, it can leave soreness or redness where the needle went in, and your provider will ask you to report anything beyond that.
The larger unknowns are about time.
No long-term safety study of sermorelin in adults exists, and the compounded products in use today are not reviewed by the FDA before sale. Is sermorelin safe? For a screened adult under medical supervision, the short-term record is reassuring. Over years of use, nobody has the data to say.
Quality is the other variable. In 2024 the FDA warned compounders about using food-grade ingredients in sterile injectables after patients reported severe chills, shaking and vomiting consistent with endotoxin contamination. That warning concerned a different product, but it applies to every compounded injection. The pharmacy matters as much as the molecule.
Who should avoid it
These hormones act as growth signals, which is why the screening visit asks about any current or past cancer before a prescription is considered. Pregnancy and breastfeeding rule it out, since no safety data exist. Children with growth concerns belong with a pediatric endocrinologist, not a wellness program.
Anyone with an untreated sleep disorder, uncontrolled blood sugar or an unmanaged thyroid problem needs that condition handled first. These hormones touch each of those systems, and the labs in the next section exist to catch them before the first dose, not after.
Why labs come first before sermorelin injections
Sermorelin injections treat a shortfall in a signal. Before anyone adds to that signal, it helps to know whether a shortfall exists, and whether something else explains the fatigue, soft midsection and poor sleep that bring most people to the question.
Those symptoms are also the classic signs you need hormone therapy, and in men they overlap almost completely with low testosterone. One draw sorts it out. At 4Ever Young the panel is paired with body composition testing, so the plan starts from measurements rather than impressions. The markers that decide this question:
- Your hormone marker, read against the reference range for your age
- Total and free testosterone, because low levels produce the same complaints and have a better studied treatment
- Thyroid function, since an underactive thyroid mimics low hormone output almost symptom for symptom
- Fasting glucose and a metabolic panel, because these hormones influence blood sugar and the baseline needs to be known
- A complete blood count and a lipid panel, which belong in any responsible starting point
Results change the plan. A man with low testosterone and a normal hormone marker is a candidate for testosterone replacement therapy, not sermorelin. A woman in perimenopause may need her hormones balanced before anything else is considered. A normal panel across the board means the symptoms have another cause, and finding it is worth more than any injection.
Labs also set the baseline you will be measured against. Hormone markers rose within four weeks of nightly use in the 1997 trials, so a recheck shows whether the medication is doing anything at all.
How to start with a licensed provider
Start with a consultation, not an order form. At 4Ever Young that visit covers your medical history, your symptoms and goals, and a comprehensive blood panel. Nothing is prescribed from a questionnaire.
Sermorelin dosage is set by the provider after labs and adjusted on follow-up labs, never copied from a forum. Product strengths differ between compounding pharmacies, and the right amount for you depends on your lab response, your weight and how you tolerate the injections. That is why this guide lists no numbers, and why a page that does should make you cautious.
Expect the first months to follow a sequence. You learn to self-inject in the evening. You keep a simple log of sleep and how you feel. You return for labs so the provider can compare your results to baseline, and from there the dose is held, adjusted or stopped. A plan without that recheck is not supervision. It is a subscription.
Supervision also means the prescription goes to a licensed compounding pharmacy, with a certificate of analysis for what is in the vial. A medication bought from a website with no prescription comes with no certificate, no provider and no one to call when something feels wrong.
Sermorelin is rarely the whole plan. For men with tested low testosterone, andropause treatment for men addresses the hormone most likely driving the symptoms, and for women hormone therapy for women does the same. A 4Ever Young membership covers the continuing care and rechecks either path requires.
Your panel comes before any prescription
A consultation and a comprehensive blood panel show whether sermorelin, hormone therapy or neither fits your results.
Find a CenterSermorelin FAQ
01Does Sermorelin Work?
Does sermorelin work? It reliably does one thing: it raises your body’s own hormone output, which two small 1997 trials measured within four weeks. Whether that turns into the sleep, energy and body composition changes people hope for has not been in adults, so treat those as possible rather than expected.
02Is Sermorelin FDA Approved?
Is sermorelin FDA approved? Not today. The brand Geref was approved in 1990 and 1997 for use in children, its maker later withdrew it from sale, and the FDA found in 2013 that the withdrawal was not for safety or effectiveness reasons. The compounded sermorelin clinics prescribe now is not FDA approved, and the FDA does not review it before it is sold.
03When Do Sermorelin Results Show?
Sermorelin results show up on paper first. Trials measured higher hormone output within four weeks of nightly injections. Anything you can feel, such as sleep or recovery, varies by person and has no timeline, which is why providers recheck labs instead of promising a date.
Wondering whether your symptoms point to a hormone imbalance, low testosterone or something else? Book a consultation →
Featured From the Blog
Featured · Testosterone
TRT Results Timeline: What People Notice in Week 2, Month 2 and Month 6
What tested low testosterone patients commonly notice as treatment settles in, and why labs are rechecked along the way.
Jan 16, 2026Read article →
Sources
- Federal Register, March 4, 2013 (78 FR 14095) – FDA determination that GEREF (sermorelin acetate) was not withdrawn from sale for reasons of safety or effectiveness
- Drugs@FDA, NDA 020443 – GEREF (sermorelin acetate) injection, approved September 26, 1997, marketing status discontinued
- U.S. Food and Drug Administration – Compounding and the FDA: Questions and Answers (compounded drugs are not FDA approved)
- Walker RF, Clinical Interventions in Aging, 2006 – Sermorelin review for adults
- Vittone J et al., Metabolism, 1997 – Nightly injections in healthy older men
- Khorram O et al., Journal of Clinical Endocrinology and Metabolism, 1997 – 16-week placebo-controlled trial in aging men and women






